Healthcare Adtech Vendor DeepIntent Bought for $627 Million
DeepIntent helps healthcare and pharma brands buy advertising. The ads may be under attack in Washington, but that didn’t stop private equity investor Vitruvian from spending $637 million to buy a majority share.